APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oxaliplatin

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.

In this report, only the finished drug is covered, exclude API.

Selected research

Industry Growth & Trends

Global Oxaliplatin Industry Growth and Trends Forecast to 2032

22 December 2025124 pages

Choose your research edition.

Industry ResearchOxaliplatin Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxaliplatin Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Oxaliplatin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxaliplatin Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxaliplatin Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy the third stage colon cancer after resecting primary tumor completely.

In this report, only the finished drug is covered, exclude API.

According to APO Research, the global Oxaliplatin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global Oxaliplatin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oxaliplatin market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oxaliplatin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oxaliplatin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Oxaliplatin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oxaliplatin Market by Company

Sanofi-Aventis

Yakult honsha

Dr Reddy's laboratories

Sun Pharmaceutical

Teva

Fresenius Kabi

Hospira

Mylan

Jiangsu Hengrui Medicine

Nanjing Pharmaceutical Factory

Jiangsu Aosaikang Pharmaceutical

Qilu Pharmaceutical

Hisun Pharmaceutical

Lunan Pharmaceutical

Luoxin

Halfsky Pharmacy

YRPG

Hainan Jinrui Pharmaceutical

Jari Pharmaceutical

Chiatai Tianqing

Oxaliplatin Segment by Type

Mannitol

Glucose Solution

Lactose Solution

Others

Oxaliplatin Segment by Application

Colorectal Cancer

Stomach Cancer

Ovarian Cancer

Others

Oxaliplatin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxaliplatin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxaliplatin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxaliplatin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Oxaliplatin companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Oxaliplatin Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Oxaliplatin Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Oxaliplatin Market Share by Region (2021-2026) Table 4. Global Oxaliplatin Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Oxaliplatin Market Share by Region (2027-2032) Table 6. Global Oxaliplatin Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Oxaliplatin Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Oxaliplatin Market Size Share by Type (2021-2026) Table 9. Global Oxaliplatin Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Oxaliplatin Market Size Share Forecasted by Type (2027-2032) Table 11. North America Oxaliplatin Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Oxaliplatin Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Oxaliplatin Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Oxaliplatin Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Oxaliplatin Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Oxaliplatin Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Oxaliplatin Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Oxaliplatin Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Oxaliplatin Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Oxaliplatin Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Oxaliplatin Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Oxaliplatin Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Oxaliplatin Market Size Share by Application (2021-2026) Table 24. Global Oxaliplatin Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Oxaliplatin Market Size Share Forecasted by Application (2027-2032) Table 26. North America Oxaliplatin Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Oxaliplatin Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Oxaliplatin Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Oxaliplatin Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Oxaliplatin Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Oxaliplatin Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Oxaliplatin Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Oxaliplatin Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Oxaliplatin Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Oxaliplatin Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Oxaliplatin Industry Trends Table 37. Oxaliplatin Industry Drivers Table 38. Oxaliplatin Industry Opportunities and Challenges Table 39. Oxaliplatin Industry Restraints Table 40. Global Oxaliplatin Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Oxaliplatin Revenue Market Share by Company (2021-2026) Table 42. Global Oxaliplatin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Oxaliplatin Key Company Headquarters & Area Served Table 44. Global Oxaliplatin Company, Product Type & Application Table 45. Global Oxaliplatin Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Oxaliplatin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Sanofi-Aventis Company Information Table 49. Sanofi-Aventis Business Overview Table 50. Sanofi-Aventis Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Sanofi-Aventis Oxaliplatin Product Portfolio Table 52. Sanofi-Aventis Recent Development Table 53. Yakult honsha Company Information Table 54. Yakult honsha Business Overview Table 55. Yakult honsha Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Yakult honsha Oxaliplatin Product Portfolio Table 57. Yakult honsha Recent Development Table 58. Dr Reddy's laboratories Company Information Table 59. Dr Reddy's laboratories Business Overview Table 60. Dr Reddy's laboratories Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Dr Reddy's laboratories Oxaliplatin Product Portfolio Table 62. Dr Reddy's laboratories Recent Development Table 63. Sun Pharmaceutical Company Information Table 64. Sun Pharmaceutical Business Overview Table 65. Sun Pharmaceutical Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sun Pharmaceutical Oxaliplatin Product Portfolio Table 67. Sun Pharmaceutical Recent Development Table 68. Teva Company Information Table 69. Teva Business Overview Table 70. Teva Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Teva Oxaliplatin Product Portfolio Table 72. Teva Recent Development Table 73. Fresenius Kabi Company Information Table 74. Fresenius Kabi Business Overview Table 75. Fresenius Kabi Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Fresenius Kabi Oxaliplatin Product Portfolio Table 77. Fresenius Kabi Recent Development Table 78. Hospira Company Information Table 79. Hospira Business Overview Table 80. Hospira Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Hospira Oxaliplatin Product Portfolio Table 82. Hospira Recent Development Table 83. Mylan Company Information Table 84. Mylan Business Overview Table 85. Mylan Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Mylan Oxaliplatin Product Portfolio Table 87. Mylan Recent Development Table 88. Jiangsu Hengrui Medicine Company Information Table 89. Jiangsu Hengrui Medicine Business Overview Table 90. Jiangsu Hengrui Medicine Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Jiangsu Hengrui Medicine Oxaliplatin Product Portfolio Table 92. Jiangsu Hengrui Medicine Recent Development Table 93. Nanjing Pharmaceutical Factory Company Information Table 94. Nanjing Pharmaceutical Factory Business Overview Table 95. Nanjing Pharmaceutical Factory Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Nanjing Pharmaceutical Factory Oxaliplatin Product Portfolio Table 97. Nanjing Pharmaceutical Factory Recent Development Table 98. Jiangsu Aosaikang Pharmaceutical Company Information Table 99. Jiangsu Aosaikang Pharmaceutical Business Overview Table 100. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product Portfolio Table 102. Jiangsu Aosaikang Pharmaceutical Recent Development Table 103. Qilu Pharmaceutical Company Information Table 104. Qilu Pharmaceutical Business Overview Table 105. Qilu Pharmaceutical Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Qilu Pharmaceutical Oxaliplatin Product Portfolio Table 107. Qilu Pharmaceutical Recent Development Table 108. Hisun Pharmaceutical Company Information Table 109. Hisun Pharmaceutical Business Overview Table 110. Hisun Pharmaceutical Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Hisun Pharmaceutical Oxaliplatin Product Portfolio Table 112. Hisun Pharmaceutical Recent Development Table 113. Lunan Pharmaceutical Company Information Table 114. Lunan Pharmaceutical Business Overview Table 115. Lunan Pharmaceutical Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Lunan Pharmaceutical Oxaliplatin Product Portfolio Table 117. Lunan Pharmaceutical Recent Development Table 118. Luoxin Company Information Table 119. Luoxin Business Overview Table 120. Luoxin Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Luoxin Oxaliplatin Product Portfolio Table 122. Luoxin Recent Development Table 123. Halfsky Pharmacy Company Information Table 124. Halfsky Pharmacy Business Overview Table 125. Halfsky Pharmacy Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Halfsky Pharmacy Oxaliplatin Product Portfolio Table 127. Halfsky Pharmacy Recent Development Table 128. YRPG Company Information Table 129. YRPG Business Overview Table 130. YRPG Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. YRPG Oxaliplatin Product Portfolio Table 132. YRPG Recent Development Table 133. Hainan Jinrui Pharmaceutical Company Information Table 134. Hainan Jinrui Pharmaceutical Business Overview Table 135. Hainan Jinrui Pharmaceutical Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Hainan Jinrui Pharmaceutical Oxaliplatin Product Portfolio Table 137. Hainan Jinrui Pharmaceutical Recent Development Table 138. Jari Pharmaceutical Company Information Table 139. Jari Pharmaceutical Business Overview Table 140. Jari Pharmaceutical Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Jari Pharmaceutical Oxaliplatin Product Portfolio Table 142. Jari Pharmaceutical Recent Development Table 143. Chiatai Tianqing Company Information Table 144. Chiatai Tianqing Business Overview Table 145. Chiatai Tianqing Oxaliplatin Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Chiatai Tianqing Oxaliplatin Product Portfolio Table 147. Chiatai Tianqing Recent Development Table 148. North America Oxaliplatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Oxaliplatin Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Oxaliplatin Market Share by Country (2021-2026) Table 151. North America Oxaliplatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Oxaliplatin Market Share Forecast by Country (2027-2032) Table 153. Europe Oxaliplatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Oxaliplatin Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Oxaliplatin Market Share by Country (2021-2026) Table 156. Europe Oxaliplatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Oxaliplatin Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Oxaliplatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Oxaliplatin Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Oxaliplatin Market Share by Country (2021-2026) Table 161. Asia-Pacific Oxaliplatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Oxaliplatin Market Share Forecast by Country (2027-2032) Table 163. Latin America Oxaliplatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Oxaliplatin Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Oxaliplatin Market Share by Country (2021-2026) Table 166. Latin America Oxaliplatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Oxaliplatin Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Oxaliplatin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Oxaliplatin Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Oxaliplatin Market Share by Country (2021-2026) Table 171. Middle East & Africa Oxaliplatin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Oxaliplatin Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Oxaliplatin Product Image Figure 3. Global Oxaliplatin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Oxaliplatin Market Size (2021-2032) & (US$ Million) Figure 5. Global Oxaliplatin Market Share by Region: 2025 VS 2032 Figure 6. Global Oxaliplatin Market Share by Region (2021-2032) Figure 7. North America Oxaliplatin Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Oxaliplatin Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Oxaliplatin Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Oxaliplatin Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Oxaliplatin Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Mannitol Image Figure 13. Global Mannitol Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Glucose Solution Image Figure 15. Global Glucose Solution Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Lactose Solution Image Figure 17. Global Lactose Solution Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Others Image Figure 19. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Global Oxaliplatin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 21. Global Oxaliplatin Market Share by Type 2025 VS 2032 Figure 22. North America Oxaliplatin Market Size Share by Type (2021-2032) Figure 23. Europe Oxaliplatin Market Size Share by Type (2021-2032) Figure 24. Asia-Pacific Oxaliplatin Market Size Share by Type (2021-2032) Figure 25. Latin America Oxaliplatin Market Size Share by Type (2021-2032) Figure 26. Middle East and Africa Oxaliplatin Market Size Share by Type (2021-2032) Figure 27. Colorectal Cancer Image Figure 28. Global Colorectal Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Stomach Cancer Image Figure 30. Global Stomach Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Ovarian Cancer Image Figure 32. Global Ovarian Cancer Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Others Image Figure 34. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Global Oxaliplatin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Oxaliplatin Market Share by Application 2025 VS 2032 Figure 37. North America Oxaliplatin Market Size Share by Application (2021-2032) Figure 38. Europe Oxaliplatin Market Size Share by Application (2021-2032) Figure 39. Asia-Pacific Oxaliplatin Market Size Share by Application (2021-2032) Figure 40. Latin America Oxaliplatin Market Size Share by Application (2021-2032) Figure 41. Middle East and Africa Oxaliplatin Market Size Share by Application (2021-2032) Figure 42. Global Top 5 and 10 Oxaliplatin Players Market Share by Revenue in 2025 Figure 43. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 44. North America Oxaliplatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. North America Oxaliplatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. North America Oxaliplatin Market Share by Country (2021-2032) Figure 47. Europe Oxaliplatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Oxaliplatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Oxaliplatin Market Share by Country (2021-2032) Figure 50. Asia-Pacific Oxaliplatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Asia-Pacific Oxaliplatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Asia-Pacific Oxaliplatin Market Share by Country (2021-2032) Figure 53. Latin America Oxaliplatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Oxaliplatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Oxaliplatin Market Share by Country (2021-2032) Figure 56. Middle East & Africa Oxaliplatin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Middle East & Africa Oxaliplatin Market Share by Country: 2021 VS 2025 VS 2032 Figure 58. Middle East & Africa Oxaliplatin Market Share by Country (2021-2032) Figure 59. Years Considered Figure 60. Research Process Figure 61. Key Executives Interviewed

Scope & coverage.

Types
  • Mannitol
  • Glucose Solution
  • Lactose Solution
  • Others
Applications
  • Colorectal Cancer
  • Stomach Cancer
  • Ovarian Cancer
  • Others
Companies covered
  • Sanofi-Aventis
  • Yakult honsha
  • Dr Reddy's laboratories
  • Sun Pharmaceutical
  • Teva
  • Fresenius Kabi
  • Hospira
  • Mylan
  • Jiangsu Hengrui Medicine
  • Nanjing Pharmaceutical Factory
  • Jiangsu Aosaikang Pharmaceutical
  • Qilu Pharmaceutical
  • Hisun Pharmaceutical
  • Lunan Pharmaceutical
  • Luoxin
  • Halfsky Pharmacy
  • YRPG
  • Hainan Jinrui Pharmaceutical
  • Jari Pharmaceutical
  • Chiatai Tianqing

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Oxaliplatin Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Oxaliplatin Market Size by Region (2021-2032)
  5. 1.4.1 Global Oxaliplatin Market Size by Region (2021-2026)
  6. 1.4.2 Global Oxaliplatin Market Size by Region (2027-2032)
  7. 1.5 Key Regions Oxaliplatin Market Size (2021-2032)
  8. 1.5.1 North America Oxaliplatin Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Oxaliplatin Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Oxaliplatin Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Oxaliplatin Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Oxaliplatin Market Size Growth Rate (2021-2032)
2 Oxaliplatin Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Mannitol
  3. 2.1.2 Glucose Solution
  4. 2.1.3 Lactose Solution
  5. 2.1.4 Others
  6. 2.2 Global Oxaliplatin Market Size by Type
  7. 2.2.1 Global Oxaliplatin Market Size Overview by Type (2021-2032)
  8. 2.2.2 Global Oxaliplatin Historic Market Size Review by Type (2021-2026)
  9. 2.2.3 Global Oxaliplatin Market Size Forecasted by Type (2027-2032)
  10. 2.3 Global Oxaliplatin Market Size by Regions
  11. 2.3.1 North America Oxaliplatin Market Size Breakdown by Type (2021-2026)
  12. 2.3.2 Europe Oxaliplatin Market Size Breakdown by Type (2021-2026)
  13. 2.3.3 Asia-Pacific Oxaliplatin Market Size Breakdown by Type (2021-2026)
  14. 2.3.4 South America Oxaliplatin Market Size Breakdown by Type (2021-2026)
  15. 2.3.5 Middle East and Africa Oxaliplatin Market Size Breakdown by Type (2021-2026)
3 Oxaliplatin Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Colorectal Cancer
  3. 3.1.2 Stomach Cancer
  4. 3.1.3 Ovarian Cancer
  5. 3.1.4 Others
  6. 3.2 Global Oxaliplatin Market Size by Application
  7. 3.2.1 Global Oxaliplatin Market Size Overview by Application (2021-2032)
  8. 3.2.2 Global Oxaliplatin Historic Market Size Review by Application (2021-2026)
  9. 3.2.3 Global Oxaliplatin Market Size Forecasted by Application (2027-2032)
  10. 3.3 Global Oxaliplatin Market Size by Regions
  11. 3.3.1 North America Oxaliplatin Market Size Breakdown by Application (2021-2026)
  12. 3.3.2 Europe Oxaliplatin Market Size Breakdown by Application (2021-2026)
  13. 3.3.3 Asia-Pacific Oxaliplatin Market Size Breakdown by Application (2021-2026)
  14. 3.3.4 South America Oxaliplatin Market Size Breakdown by Application (2021-2026)
  15. 3.3.5 Middle East and Africa Oxaliplatin Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Oxaliplatin Industry Trends
  2. 4.2 Oxaliplatin Industry Drivers
  3. 4.3 Oxaliplatin Industry Opportunities and Challenges
  4. 4.4 Oxaliplatin Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Oxaliplatin Revenue (2021-2026)
  2. 5.2 Global Oxaliplatin Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Oxaliplatin Key Company Headquarters & Area Served
  4. 5.4 Global Oxaliplatin Company, Product Type & Application
  5. 5.5 Global Oxaliplatin Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Oxaliplatin Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Oxaliplatin Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Oxaliplatin Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Sanofi-Aventis
  2. 6.1.1 Sanofi-Aventis Company Information
  3. 6.1.2 Sanofi-Aventis Business Overview
  4. 6.1.3 Sanofi-Aventis Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi-Aventis Oxaliplatin Product Portfolio
  6. 6.1.5 Sanofi-Aventis Recent Developments
  7. 6.2 Yakult honsha
  8. 6.2.1 Yakult honsha Company Information
  9. 6.2.2 Yakult honsha Business Overview
  10. 6.2.3 Yakult honsha Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Yakult honsha Oxaliplatin Product Portfolio
  12. 6.2.5 Yakult honsha Recent Developments
  13. 6.3 Dr Reddy's laboratories
  14. 6.3.1 Dr Reddy's laboratories Company Information
  15. 6.3.2 Dr Reddy's laboratories Business Overview
  16. 6.3.3 Dr Reddy's laboratories Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Dr Reddy's laboratories Oxaliplatin Product Portfolio
  18. 6.3.5 Dr Reddy's laboratories Recent Developments
  19. 6.4 Sun Pharmaceutical
  20. 6.4.1 Sun Pharmaceutical Company Information
  21. 6.4.2 Sun Pharmaceutical Business Overview
  22. 6.4.3 Sun Pharmaceutical Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sun Pharmaceutical Oxaliplatin Product Portfolio
  24. 6.4.5 Sun Pharmaceutical Recent Developments
  25. 6.5 Teva
  26. 6.5.1 Teva Company Information
  27. 6.5.2 Teva Business Overview
  28. 6.5.3 Teva Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Teva Oxaliplatin Product Portfolio
  30. 6.5.5 Teva Recent Developments
  31. 6.6 Fresenius Kabi
  32. 6.6.1 Fresenius Kabi Company Information
  33. 6.6.2 Fresenius Kabi Business Overview
  34. 6.6.3 Fresenius Kabi Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Fresenius Kabi Oxaliplatin Product Portfolio
  36. 6.6.5 Fresenius Kabi Recent Developments
  37. 6.7 Hospira
  38. 6.7.1 Hospira Company Information
  39. 6.7.2 Hospira Business Overview
  40. 6.7.3 Hospira Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Hospira Oxaliplatin Product Portfolio
  42. 6.7.5 Hospira Recent Developments
  43. 6.8 Mylan
  44. 6.8.1 Mylan Company Information
  45. 6.8.2 Mylan Business Overview
  46. 6.8.3 Mylan Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Mylan Oxaliplatin Product Portfolio
  48. 6.8.5 Mylan Recent Developments
  49. 6.9 Jiangsu Hengrui Medicine
  50. 6.9.1 Jiangsu Hengrui Medicine Company Information
  51. 6.9.2 Jiangsu Hengrui Medicine Business Overview
  52. 6.9.3 Jiangsu Hengrui Medicine Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Jiangsu Hengrui Medicine Oxaliplatin Product Portfolio
  54. 6.9.5 Jiangsu Hengrui Medicine Recent Developments
  55. 6.10 Nanjing Pharmaceutical Factory
  56. 6.10.1 Nanjing Pharmaceutical Factory Company Information
  57. 6.10.2 Nanjing Pharmaceutical Factory Business Overview
  58. 6.10.3 Nanjing Pharmaceutical Factory Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Nanjing Pharmaceutical Factory Oxaliplatin Product Portfolio
  60. 6.10.5 Nanjing Pharmaceutical Factory Recent Developments
  61. 6.11 Jiangsu Aosaikang Pharmaceutical
  62. 6.11.1 Jiangsu Aosaikang Pharmaceutical Company Information
  63. 6.11.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  64. 6.11.3 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 Jiangsu Aosaikang Pharmaceutical Oxaliplatin Product Portfolio
  66. 6.11.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  67. 6.12 Qilu Pharmaceutical
  68. 6.12.1 Qilu Pharmaceutical Company Information
  69. 6.12.2 Qilu Pharmaceutical Business Overview
  70. 6.12.3 Qilu Pharmaceutical Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Qilu Pharmaceutical Oxaliplatin Product Portfolio
  72. 6.12.5 Qilu Pharmaceutical Recent Developments
  73. 6.13 Hisun Pharmaceutical
  74. 6.13.1 Hisun Pharmaceutical Company Information
  75. 6.13.2 Hisun Pharmaceutical Business Overview
  76. 6.13.3 Hisun Pharmaceutical Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Hisun Pharmaceutical Oxaliplatin Product Portfolio
  78. 6.13.5 Hisun Pharmaceutical Recent Developments
  79. 6.14 Lunan Pharmaceutical
  80. 6.14.1 Lunan Pharmaceutical Company Information
  81. 6.14.2 Lunan Pharmaceutical Business Overview
  82. 6.14.3 Lunan Pharmaceutical Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Lunan Pharmaceutical Oxaliplatin Product Portfolio
  84. 6.14.5 Lunan Pharmaceutical Recent Developments
  85. 6.15 Luoxin
  86. 6.15.1 Luoxin Company Information
  87. 6.15.2 Luoxin Business Overview
  88. 6.15.3 Luoxin Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Luoxin Oxaliplatin Product Portfolio
  90. 6.15.5 Luoxin Recent Developments
  91. 6.16 Halfsky Pharmacy
  92. 6.16.1 Halfsky Pharmacy Company Information
  93. 6.16.2 Halfsky Pharmacy Business Overview
  94. 6.16.3 Halfsky Pharmacy Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Halfsky Pharmacy Oxaliplatin Product Portfolio
  96. 6.16.5 Halfsky Pharmacy Recent Developments
  97. 6.17 YRPG
  98. 6.17.1 YRPG Company Information
  99. 6.17.2 YRPG Business Overview
  100. 6.17.3 YRPG Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 YRPG Oxaliplatin Product Portfolio
  102. 6.17.5 YRPG Recent Developments
  103. 6.18 Hainan Jinrui Pharmaceutical
  104. 6.18.1 Hainan Jinrui Pharmaceutical Company Information
  105. 6.18.2 Hainan Jinrui Pharmaceutical Business Overview
  106. 6.18.3 Hainan Jinrui Pharmaceutical Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Hainan Jinrui Pharmaceutical Oxaliplatin Product Portfolio
  108. 6.18.5 Hainan Jinrui Pharmaceutical Recent Developments
  109. 6.19 Jari Pharmaceutical
  110. 6.19.1 Jari Pharmaceutical Company Information
  111. 6.19.2 Jari Pharmaceutical Business Overview
  112. 6.19.3 Jari Pharmaceutical Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Jari Pharmaceutical Oxaliplatin Product Portfolio
  114. 6.19.5 Jari Pharmaceutical Recent Developments
  115. 6.20 Chiatai Tianqing
  116. 6.20.1 Chiatai Tianqing Company Information
  117. 6.20.2 Chiatai Tianqing Business Overview
  118. 6.20.3 Chiatai Tianqing Oxaliplatin Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Chiatai Tianqing Oxaliplatin Product Portfolio
  120. 6.20.5 Chiatai Tianqing Recent Developments
7 North America
  1. 7.1 North America Oxaliplatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Oxaliplatin Market Size by Country (2021-2026)
  3. 7.3 North America Oxaliplatin Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Oxaliplatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Oxaliplatin Market Size by Country (2021-2026)
  3. 8.3 Europe Oxaliplatin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Oxaliplatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Oxaliplatin Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Oxaliplatin Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Oxaliplatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Oxaliplatin Market Size by Country (2021-2026)
  3. 10.3 South America Oxaliplatin Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Oxaliplatin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Oxaliplatin Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Oxaliplatin Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst